Search
for
Did you mean Clinical Assessment?
Learn
5 / 27 resultslearn Verteporfin
chemical that might completely regrow follicles from hair transplant extractions
learn Pyrilutamide
highly targeted anti-androgen that might have minimal systemic effects
learn Caffeine
the stimulant you know and love can be used topically to stimulate hair
learn GT20029
research compound made to degrade androgen receptors in scalp
Research
5 / 1000+ results
research Clinical Severity Does Not Reliably Predict Quality of Life in Women With Alopecia Areata, Telogen Effluvium, or Androgenic Alopecia
How bad a woman's hair loss is doesn't always match how it affects her happiness and daily life.
research Histopathological Examination and Evaluation of Serum Vitamin D Levels in Alopecia: Is It Necessary?
Skin biopsies are recommended for confirming alopecia diagnosis due to variability in clinical assessments; the link between vitamin D levels and alopecia is unclear.
research Trichoscopic Stages of Dissecting Cellulitis: A Potential Complementary Tool to Clinical Assessment
Trichoscopy can help diagnose and monitor the progression of dissecting cellulitis.
research Clinical and Instrumental Characterization of Hair and Scalp Aging in Nonbalding Caucasian Women
Aging significantly affects the hair and scalp of nonbalding Caucasian women, with changes that differ from male pattern baldness.
research Monitoring of Clinical Signs in Goats with Transmissible Spongiform Encephalopathies
Goats with BSE or scrapie show varying symptoms, and using only clinical signs may not detect all scrapie cases.
Community Join
5 / 936 resultscommunity COMPLETE OVERVIEW of the Treatment of androgenetic alopecia in men
Male androgenetic alopecia is commonly treated with topical minoxidil and oral finasteride, both requiring continuous use. Other options include hair restoration surgery, dutasteride, light therapy, and camouflaging agents.
community Why is nobody talking about the new study results for Pyrilutamide??
Pyrilutamide shows promising hair growth results, but skepticism exists due to potential biases and lack of blinding in the study. Concerns about side effects and legitimacy of the product persist, with comparisons to finasteride and discussions on post-finasteride syndrome.
community GT20029 China Phase II Trial For AGA Reached Primary Endpoint
The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.
community Phase II for Technoderma Therepeutic's TDM-105795 set to begin in April tentatively
Phase II for TDM-105795 for Androgenic Alopecia is set to begin in April 2023. The study aims to evaluate the efficacy and safety of TDM-105795 in male subjects.
community Protac degradation of the androgen receptor in mice shows good efficacy and no systemic drug could be found
The efficacy of degrading the androgen receptor through dermal application in DP cells, a delivery system for topical drugs that involves dissolving microneedles, and rosemary oil as an alternative anti-androgen.